| For: | Su GG, Pan KH, Zhao NF, Fang SH, Yang DH, Zhou Y. Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. World J Gastroenterol 2004; 10(6): 910-912 [PMID: 15040044 DOI: 10.3748/wjg.v10.i6.910] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i6/910.htm |
| Number | Citing Articles |
| 1 |
Tokio Sugiura, Takeshi Endo, Koichi Ito, Nobuhiro Suzumori, Shinji Saitoh, Yasuhito Tanaka. Lamivudine treatment during pregnancy successfully prevented mother-to-child transmission of hepatitis B virus infection. Kanzo 2012; 53(10) doi: 10.2957/kanzo.53.610
|
| 2 |
Silvia Sookoian. Effect of pregnancy on pre-existing liver disease: Chronic viral hepatitis. Annals of Hepatology 2006; 5(3) doi: 10.1016/S1665-2681(19)32009-5
|
| 3 |
Saketh R. Guntupalli, Jay Steingrub. Hepatic disease and pregnancy: An overview of diagnosis and management. Critical Care Medicine 2005; 33(Supplement) doi: 10.1097/01.CCM.0000182555.39644.7F
|
| 4 |
W.‐M. Xu, Y.‐T. Cui, L. Wang, H. Yang, Z.‐Q. Liang, X.‐M. Li, S.‐L. Zhang, F.‐Y. Qiao, F. Campbell, C.‐N. Chang, S. Gardner, M. Atkins. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double‐blind, placebo‐controlled study. Journal of Viral Hepatitis 2009; 16(2) doi: 10.1111/j.1365-2893.2008.01056.x
|
| 5 |
Jiří Hlušička, Aleš Žák. Dyslipidaemia in Liver Diseases. Folia Biologica 2024; 70(5-6) doi: 10.14712/fb2024070050239
|
| 6 |
Jay H. Hoofnagle, Edward Doo, T. Jake Liang, Russell Fleischer, Anna S.F. Lok. Management of hepatitis B. Hepatology 2007; 45(4) doi: 10.1002/hep.21627
|
| 7 |
Lung-Yi Mak, Wai-Kay Seto, Ching-Lung Lai, Man-Fung Yuen. DNA polymerase inhibitors for treating hepatitis B: a safety evaluation. Expert Opinion on Drug Safety 2016; 15(3) doi: 10.1517/14740338.2016.1139573
|
| 8 |
Min Deng, Xin Zhou, Sheng Gao, Shi-Gui Yang, Bing Wang, Hua-Zhong Chen, Bing Ruan. The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysis. Virology Journal 2012; 9(1) doi: 10.1186/1743-422X-9-185
|
| 9 |
Wikrom Karnsakul, Kathleen B. Schwarz. Infectious Diseases of the Fetus and Newborn. 2011; doi: 10.1016/B978-1-4160-6400-8.00025-0
|
| 10 |
Golasa Samadi Kochaksaraei, Abdel A. Shaheen, Cynthia H. Seow, Herman W. Barkema, Carla S. Coffin. Tenofovir disoproxil fumarate therapy to prevent hepatitis B virus vertical transmission—A review of maternal and infant outcomes. Liver International 2022; 42(8) doi: 10.1111/liv.15249
|
| 11 |
Soheil Tavakolpour, Mohammad Darvishi, Hajar Sadat Mirsafaei, Mojtaba Ghasemiadl. Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B infection during pregnancy: a systematic review. Infectious Diseases 2018; 50(2) doi: 10.1080/23744235.2017.1384957
|
| 12 |
Jie Chen, Ling Yan, Feng‐Cai Zhu, Jian‐Xun Liu, Rong‐Cheng Li, Fu‐Zhen Wang, Jie Li, Hui Zhuang. Amino acid polymorphism in the reverse transcriptase region of hepatitis B virus and the relationship with nucleos(t)ide analogues treatment for preventing mother‐to‐infant transmission. Journal of Medical Virology 2014; 86(8) doi: 10.1002/jmv.23948
|
| 13 |
Khalid Mumtaz, Umair Syed Ahmed, Nadeem F Zuberi, Sumaira Salamat, Wasim Jafri. Lamivudine during pregnancy for preventing hepatitis B virus infection in newborns. Cochrane Database of Systematic Reviews 2010; doi: 10.1002/14651858.CD008718
|
| 14 |
Emanuela Zappulo, Agnese Giaccone, Nicola Schiano Moriello, Ivan Gentile. Pharmacological approaches to prevent vertical transmission of HIV and HBV. Expert Review of Clinical Pharmacology 2022; 15(7) doi: 10.1080/17512433.2022.2105202
|
| 15 |
John A Almeida, Stephen M Riordan. The safety of pharmacological therapies for gastrointestinal conditions encountered during pregnancy. Expert Opinion on Drug Safety 2007; 6(5) doi: 10.1517/14740338.6.5.493
|
| 16 |
Hee Yeon Kim, Jong Young Choi, Chung-Hwa Park, Jeong Won Jang, Chang Wook Kim, Si Hyun Bae, Seung Kew Yoon, Jin Mo Yang, Chang Don Lee, Young Sok Lee. Outcome after discontinuing antiviral agents during pregnancy in women infected with hepatitis B virus. Journal of Clinical Virology 2013; 56(4) doi: 10.1016/j.jcv.2012.11.019
|
| 17 |
Maureen M. Jonas. Hepatitis B and pregnancy: an underestimated issue. Liver International 2009; 29(s1) doi: 10.1111/j.1478-3231.2008.01933.x
|
| 18 |
J C Dunkelberg, E M F Berkley, K W Thiel, K K Leslie. Hepatitis B and C in pregnancy: a review and recommendations for care. Journal of Perinatology 2014; 34(12) doi: 10.1038/jp.2014.167
|
| 19 |
Md. Fazal Karim, Mamun Al-Mahtab, Salimur Rahman, Mobin Khan. Pitfalls in management of chronic hepatitis B: Report of four cases from Bangladesh. Clinical and Experimental Medical Journal 2010; 4(1) doi: 10.1556/CEMED.4.2010.1.22
|
| 20 |
Neelam Aggarwal, Neha Negi, Aakash Aggarwal, Vijay Bodh, Radha K. Dhiman. Pregnancy with Portal Hypertension. Journal of Clinical and Experimental Hepatology 2014; 4(2) doi: 10.1016/j.jceh.2014.05.014
|
| 21 |
Robert J. Fontana. Side effects of long-term oral antiviral therapy for hepatitis B #. Hepatology 2009; 49(Suppl. 5) doi: 10.1002/hep.22885
|
| 22 |
|
| 23 |
G. Ducarme, M. Schnee, V. Dochez. Hepatitis y embarazo. EMC - Ginecología-Obstetricia 2016; 52(2) doi: 10.1016/S1283-081X(16)77884-2
|
| 24 |
Xingfei Pan, Jingsi Chen, Liyang Zhou, Xueting Ou, Fang He, Yifen Liu, Shuo Zheng, Haibin Wang, Bin Cao, Zhijian Wang, Huishu Liu, Guocheng Liu, Zhenyu Huang, Guanxin Shen, Shiliang Liu, Dunjin Chen. Efficacy and safety of continuous antiviral therapy from preconception to prevent perinatal transmission of hepatitis B virus. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-70644-4
|
| 25 |
Robert Perrillo. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 2010; doi: 10.1016/B978-1-4160-6189-2.00078-0
|
| 26 |
Mitchell S. Cappell. Hepatic Disorders Mildly to Moderately Affected by Pregnancy: Medical and Obstetric Management. Medical Clinics of North America 2008; 92(4) doi: 10.1016/j.mcna.2008.03.003
|
| 27 |
|
| 28 |
M. Yu, Q. Jiang, Y. Ji, H. Jiang, K. Wu, L. Ju, X. Tang, M. Wu. The efficacy and safety of antiviral therapy with lamivudine to stop the vertical transmission of hepatitis B virus. European Journal of Clinical Microbiology & Infectious Diseases 2012; 31(9) doi: 10.1007/s10096-012-1557-2
|
| 29 |
CHIEN-YI CHEN, MEI-HWEI CHANG. HEPATITIS B AND PREGNANCY, THE SCIENTIFIC BASIS FOR PERINATAL PREVENTION. Fetal and Maternal Medicine Review 2010; 21(2) doi: 10.1017/S0965539510000021
|
| 30 |
Y. Bacq. Hépatite virale B et Grossesse. Gastroentérologie Clinique et Biologique 2008; 32(1) doi: 10.1016/S0399-8320(08)73260-3
|
| 31 |
Ayaz Matin, David A. Sass. Liver Disease in Pregnancy. Gastroenterology Clinics of North America 2011; 40(2) doi: 10.1016/j.gtc.2011.03.010
|
| 32 |
Minmin Yu, Ying Ji, Hongxiu Jiang, Lili Ju, Kaihua Wu, Naiying Kan. Efficacy of peripartum antiviral treatment for hepatic failure due to hepatitis B virus. International Journal of Gynecology & Obstetrics 2011; 114(1) doi: 10.1016/j.ijgo.2011.03.004
|
| 33 |
Eleri S. W. Wilson‐Davies, William F. Carman. Clinical Dilemmas in Viral Liver Disease. 2010; doi: 10.1002/9781444319590.ch30
|
| 34 |
Sailesh Kumar, Mrinalini Balki, Catherine Williamson, Eliana Castillo, Deborah M. Money. de Swiet's Medical Disorders in Obstetric Practice. 2010; doi: 10.1002/9781444323016.ch9
|
| 35 |
TRAM T. TRAN. Hepatitis B. Clinical Obstetrics & Gynecology 2012; 55(2) doi: 10.1097/GRF.0b013e318251097a
|
| 36 |
Uma Mahadevan, Sunanda Kane. American Gastroenterological Association Institute Technical Review on the Use of Gastrointestinal Medications in Pregnancy. Gastroenterology 2006; 131(1) doi: 10.1053/j.gastro.2006.04.049
|
| 37 |
Maya Gambarin-Gelwan. Hepatitis B in Pregnancy. Clinics in Liver Disease 2007; 11(4) doi: 10.1016/j.cld.2007.08.004
|
| 38 |
Shahnaz Sali, Mohammad Darvishi, Mojtaba GhasemiAdl, Meisam Akhlaghdoust, Azin Mirzazadeh, Somayeh Elikaei Behjati, Hossein Sheikh-Zeinolabedini, Shervin Shokouhi, Soheil Tavakolpour. Comparing the Efficacy and Safety of Treating Chronic Hepatitis B Infection during Pregnancy with Lamivudine, Telbivudine, and Tenofovir: A Meta-analysis. Journal of Clinical and Translational Hepatology 2019; (X) doi: 10.14218/JCTH.2019.00021
|
| 39 |
Marion G. Peters. Special populations with hepatitis B virus infection #. Hepatology 2009; 49(Suppl. 5) doi: 10.1002/hep.22965
|
| 40 |
Corinne Buchanan, Tram T. Tran. Management of Chronic Hepatitis B in Pregnancy. Clinics in Liver Disease 2010; 14(3) doi: 10.1016/j.cld.2010.05.008
|
| 41 |
Jeng-Hsiu Hung, Chi-Jen Chu, Pi-Lin Sung, Chih-Yao Chen, Kuan-Chong Chao, Ming-Jie Yang, Selena Chia-Yi Hung. Lamivudine Therapy in the Treatment of Chronic Hepatitis B with Acute Exacerbation During Pregnancy. Journal of the Chinese Medical Association 2008; 71(3) doi: 10.1016/S1726-4901(08)70009-1
|
| 42 |
Pai-Jong Stacy Tsai, Ann Chang, Seiji Yamada, Naoky Tsai, Marguerite Lisa Bartholomew. Use of Tenofovir Disoproxil Fumarate in Highly Viremic, Hepatitis B Mono-Infected Pregnant Women. Digestive Diseases and Sciences 2014; 59(11) doi: 10.1007/s10620-014-3230-3
|
| 43 |
Huihui Zeng, Haodong Cai, Ying Wang, Ying Shen. Growth and development of children prenatally exposed to telbivudine administered for the treatment of chronic hepatitis B in their mothers. International Journal of Infectious Diseases 2015; 33 doi: 10.1016/j.ijid.2014.09.002
|
| 44 |
M. Liu, H. Cai, W. Yi. Safety of telbivudine treatment for chronic hepatitis B for the entire pregnancy. Journal of Viral Hepatitis 2013; 20(s1) doi: 10.1111/jvh.12066
|
| 45 |
Manoj Kumar, Shiv K Sarin. Pharmacology, clinical efficacy and safety of lamivudine in hepatitis B virus infection. Expert Review of Gastroenterology & Hepatology 2008; 2(4) doi: 10.1586/17474124.2.4.465
|
| 46 |
Kumar Visvanathan, Geoff Dusheiko, Michelle Giles, May-Ling Wong, Nghi Phung, Susan Walker, Suong Le, Seng Gee Lim, Ed Gane, Meng Ngu, Winita Hardikar, Ben Cowie, Scott Bowden, Simone Strasser, Miriam Levy, Joe Sasaduesz. Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders. Gut 2016; 65(2) doi: 10.1136/gutjnl-2015-310317
|
| 47 |
Michelle L. Giles, Kumar Visvanathan, Sharon R. Lewin, Joe Sasadeusz. Chronic Hepatitis B Infection and Pregnancy. Obstetrical & Gynecological Survey 2012; 67(1) doi: 10.1097/OGX.0b013e31823e464b
|
| 48 |
Uma Mahadevan. Gastrointestinal medications in pregnancy. Best Practice & Research Clinical Gastroenterology 2007; 21(5) doi: 10.1016/j.bpg.2007.06.002
|
| 49 |
G. Benoist, I. Ollivier, B. Viaris de Lesegno, S. Gouarin, M. Herlicoviez. Le diagnostic prénatal en pratique. 2011; doi: 10.1016/B978-2-294-70962-3.00035-5
|
| 50 |
Maki Koh, Jun Shinohara, Yasushi Hongo, Tadashi Okazaki, Kimitaka Takitani, Hiroshi Tamai. Case treated with triple therapy of lamivudine, interferon‐β and prednisolone for acute exacerbation of chronic hepatitis B during pregnancy. Hepatology Research 2013; 43(4) doi: 10.1111/j.1872-034X.2012.01077.x
|
| 51 |
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection. Journal of Hepatology 2012; 57(1) doi: 10.1016/j.jhep.2012.02.010
|
| 52 |
Mark S. Sulkowski. Management of Hepatic Complications in HIV‐Infected Persons. The Journal of Infectious Diseases 2008; 197(s3) doi: 10.1086/533414
|
| 53 |
Grace L. Su. Pregnancy and liver disease. Current Gastroenterology Reports 2008; 10(1) doi: 10.1007/s11894-008-0004-0
|
| 54 |
Silvia Degli Esposti, John F. Reinus. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 2010; doi: 10.1016/B978-1-4160-6189-2.00038-X
|
| 55 |
Swati Sinha, Manoj Kumar. Pregnancy and chronic hepatitis B virus infection. Hepatology Research 2010; 40(1) doi: 10.1111/j.1872-034X.2009.00597.x
|
| 56 |
Wikrom Karnsakul, Kathleen B. Schwarz. Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant. 2025; doi: 10.1016/B978-0-323-79525-8.00036-6
|
| 57 |
Sumona Saha, Nancy Reau. Yamada' s Textbook of Gastroenterology. 2015; doi: 10.1002/9781118512074.ch46
|
| 58 |
Jennifer Tan, Bijal Surti, Sammy Saab. Pregnancy and cirrhosis. Liver Transplantation 2008; 14(8) doi: 10.1002/lt.21572
|
| 59 |
Nancy Leung. Chronic hepatitis B in Asian women of childbearing age. Hepatology International 2009; 3(S1) doi: 10.1007/s12072-009-9142-1
|
| 60 |
Wolfram H. Gerlich, Michael Kann. Topley & Wilson's Microbiology and Microbial Infections. 2010; doi: 10.1002/9780470688618.taw0261
|
| 61 |
Hua Xu, Teng Zeng, Jun-Ying Liu, Yu Lei, Shan Zhong, Yun-Jian Sheng, Zhi Zhou, Hong Ren. Measures to Reduce Mother-to-Child Transmission of Hepatitis B Virus in China: A Meta-Analysis. Digestive Diseases and Sciences 2014; 59(2) doi: 10.1007/s10620-013-2918-0
|